Immucell Corp
ICCCNasdaqCIK 811641HealthcareFiscal year ends Dec 31
Reports and events: 335 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1310:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-032465 |
| 2026-08-1320:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027668 |
| 2026-08-1320:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027667 |
| 2026-07-0920:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-023199 |
| 2026-06-1718:19 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-020926 |
| 2026-06-1020:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-020154 |
| 2026-05-1420:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017049 |
| 2026-05-1420:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017045 |
| 2026-05-1320:07 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001437749-26-016719 |
| 2026-05-0821:00 ET | 8-K | 1.01 Entry into a material agreement | 0001437749-26-015945 |
| 2026-04-2412:00 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001437749-26-013234 |
| 2026-04-1423:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-012182 |
| 2026-04-0820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-011757 |
| 2026-03-3021:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010339 |
| 2026-03-1820:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-008842 |
| 2026-03-0421:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-006912 |
| 2026-02-0921:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-003514 |
| 2026-02-0222:22 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-002685 |
| 2026-01-0821:13 ET | 8-K | 2.02 Results of operations; 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-000885 |
| 2025-12-2913:00 ET | 8-K | 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038773 |
| 2025-11-2021:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-289897 |
| 2025-11-1321:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034817 |
| 2025-11-1321:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034819 |
| 2025-11-0421:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-033017 |
| 2025-10-0720:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-030631 |
| 2025-09-3020:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-030110 |
| 2025-08-2512:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-080110 |
| 2025-08-1420:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076635 |
| 2025-08-1420:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076633 |
| 2025-08-1220:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-074983 |
| 2025-07-0912:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-062192 |
| 2025-06-2519:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-057768 |
| 2025-06-1718:49 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-055144 |
| 2025-05-1420:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-043287 |
| 2025-05-1420:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-043290 |
| 2025-04-2420:08 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001213900-25-035059 |
| 2025-04-0820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-029914 |
| 2025-04-0720:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-029407 |
| 2025-03-2820:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001013762-25-004072 |
| 2025-02-2521:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-017067 |
| 2025-01-1621:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-004200 |
| 2025-01-1012:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-002326 |
| 2024-12-0921:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-106933 |
| 2024-12-0221:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-104543 |
| 2024-11-1321:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-097450 |
| 2024-11-1321:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-097449 |
| 2024-10-0820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-086275 |
| 2024-09-2415:55 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-081304 |
| 2024-09-1717:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001744329-24-000005 |
| 2024-08-2720:32 ET | SC 13D | Ownership report, active investor | 0001193125-24-207799 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.